Open AccessStroke Prevention in Atrial Fibrillation in the Very Elderly: Anticoagulant Therapy Is No Longer a Sin
Author(s) -
Ansell Jack
Publication year - 2017
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.117.006864
Subject(s) - medicine , atrial fibrillation , anticoagulant therapy , stroke (engine) , discontinuation , anticoagulant , cardiology , intensive care medicine , engineering , mechanical engineering
It is well established that older individuals with atrial fibrillation (AF) are less likely to receive oral anticoagulant (OAC) therapy compared with their younger counterparts,[1][1], [2][2] and when treated with vitamin K antagonists (VKAs), there is a relatively high rate of discontinuation